Beaverton, Oregon Clinical Trials

A listing of Beaverton, Oregon clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 53 clinical trials
Effects of a Specific Substance in Smokers

Although rates of cigarette use are declining, the proportion of nondaily smokers is rising, particularly among young adults. Among young adults, nondaily smoking is associated with negative health consequences and, for some, may lead to the establishment of life-long smoking patterns. The goal of this project is to understand the …

Oregon Health and Science University
 (5.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) Before and During Treatment With Ocrelizumab

This is an open-label, multicenter study that includes a main study for all participants enrolled and an optional cerebrospinal fluid (CSF) sub-study. Self-identified African American (AA) and Hispanic or Latin American (HA) participants with a diagnosis of relapsing multiple sclerosis (RMS) will be enrolled. The treating neurologist must make an …

Providence Multiple Sclerosis Center
 (1.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +30 other locations
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.

carcinosarcoma
paclitaxel
platinum-based chemotherapy
olaparib
immunomodulator
Research Site
 (3.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +94 other locations
None

Providence Portland Medical Center
 (1.9 away) Contact site
  • 0 views
  • 19 May, 2025
  • +19 other locations
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.

aphasia
progranulin
pick's disease
dementia
Oregon Health and Science University
 (5.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +46 other locations
Study Details  

 

Portland Site
 (6.5 away)
  • 0 views
  • 19 Feb, 2024
  • 1 location
2019-06 TRISCEND Study

Early feasibility study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

tricuspid valve replacement
medical therapy
Oregon Health & Science University
 (5.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
A Safety and Efficacy Study Evaluating CTX120 in Subjects With Relapsed or Refractory Multiple Myeloma

This is a single-arm, open-label, multicenter, Phase 1 study evaluating the safety and efficacy of CTX120 in subjects with relapsed or refractory multiple myeloma.

refractory multiple myeloma
multiple myeloma
Research Site 3
 (5.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy …

folfox regimen
celiac disease
esophageal cancer
solid tumor
absolute neutrophil count
Providence Saint Vincent Medical Center
 (1.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +254 other locations
Expanded Access of Omidubicel for Allogeneic Transplantation in Patients With Hematological Malignancies

Omidubicel is an investigational therapy for patients with high-risk hematologic malignancies.

investigational treatment
allogeneic transplantation
cancer
hematologic malignancy
Oregon Health & Science University
 (5.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations